Minting lottery: solo miner creates a BTC block against all odds
Raffaele Redi •
1530
1530
3SBio Inc. develops, manufactures, markets, and sells biopharmaceuticals. The company's primary products include TPIAO, a recombinant human thrombopoietin for thrombocytopenia; Yisaipu, a tumour necrosis factor for treating rheumatoid arthritis, ankylosing spondylitis, and psoriasis; and EPIAO, a recombinant human erythropoietin for the treatment of anemia associated with chronic kidney disease (CKD), chemotherapy-induced anemia, and reduction of allogeneic blood transfusion in surgery patients. Its primary products also comprise SEPO, a recombinant human erythropoietin for anemia associated with CKD and chemotherapy; Byetta/Bydureon, an exenatide injection to improve glycemic control in adults with type-2 diabetes mellitus; and Qiming Keli for retinopathy caused by type-2 diabetes. In addition, the company offers Ruisiyi to treat advanced breast cancer; Wanwei for treating vomiting caused by cytotoxic chemotherapy; and Intefen to treat lymphatic or hematopoietic malignancies and viral infections. Further, it provides Inleusin for renal cell carcinoma, melanoma, thoracic fluid build-up caused by cancer, and tuberculosis; Etanercept for moderate to severe rheumatoid arthritis and plaque psoriasis, and active ankylosing spondylitis; and Sparin for prophylaxis and vein thrombosis, and to prevent clotting during hemodialysis. Additionally, the company offers Mandi for male-pattern alopecia and alopecia areata; Aiyishu for iron-deficiency anemia; Disu to prevent and treat chronic bronchitis, colds, and asthma; Jiannipai to prevent acute rejection after renal transplantation; and Humulin for diabetes, as well as contract development and manufacturing, trading, project management and consultation, and technology services. The company markets its products through in-house sales and marketing team, as well as distributors and third-party promoters. 3SBio Inc. was incorporated in 2006 and is headquartered in Shenyang, the People's Republic of China.
White Paper Declaration
White Paper Declaration
1BTC
Invest
20BTC
Profit
Leverage:
x20
The Power Of Leverage
Trade in the big leagues with 100 Bitcoin for every 1 Bitcoin you put in
1530 price history
| Date | Close | Change | Change(%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Sep 29, 2022 | 5.40 | -0.05 | -0.92% | 5.45 | 5.55 | 5.20 |
| Sep 28, 2022 | 5.40 | 0.05 | 0.93% | 5.35 | 5.45 | 5.35 |
| Sep 27, 2022 | 5.45 | 0.05 | 0.93% | 5.40 | 5.45 | 5.25 |
| Sep 26, 2022 | 5.40 | -0.05 | -0.92% | 5.45 | 5.55 | 5.40 |
| Sep 23, 2022 | 5.50 | 0.10 | 1.85% | 5.40 | 5.55 | 5.35 |
| Sep 22, 2022 | 5.40 | 0.10 | 1.89% | 5.30 | 5.40 | 5.15 |
| Sep 21, 2022 | 5.25 | -0.10 | -1.87% | 5.35 | 5.35 | 5.25 |
| Sep 20, 2022 | 5.35 | -0.05 | -0.93% | 5.40 | 5.45 | 5.35 |
| Sep 19, 2022 | 5.40 | 0.05 | 0.93% | 5.35 | 5.45 | 5.30 |
| Sep 16, 2022 | 5.40 | 0.10 | 1.89% | 5.30 | 5.45 | 5.30 |
| Sep 15, 2022 | 5.40 | 0.10 | 1.89% | 5.30 | 5.45 | 5.30 |
| Sep 14, 2022 | 5.30 | 0.10 | 1.92% | 5.20 | 5.30 | 5.20 |
| Sep 13, 2022 | 5.25 | -0.25 | -4.55% | 5.50 | 5.50 | 5.15 |
| Sep 9, 2022 | 5.60 | 0.25 | 4.67% | 5.35 | 5.60 | 5.35 |
| Sep 8, 2022 | 5.45 | 0.05 | 0.93% | 5.40 | 5.45 | 5.20 |
| Sep 7, 2022 | 5.35 | 0.25 | 4.90% | 5.10 | 5.40 | 4.95 |
| Sep 6, 2022 | 5.10 | -0.05 | -0.97% | 5.15 | 5.20 | 5.10 |
| Sep 5, 2022 | 5.15 | -0.15 | -2.83% | 5.30 | 5.30 | 5.10 |
| Sep 2, 2022 | 5.25 | 0.05 | 0.96% | 5.20 | 5.30 | 5.15 |
| Sep 1, 2022 | 5.20 | 0.10 | 1.96% | 5.10 | 5.20 | 5.05 |